This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
4gmi
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571== | ==BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571== | ||
| - | <StructureSection load='4gmi' size='340' side='right' caption='[[4gmi]], [[Resolution|resolution]] 1.80Å' scene=''> | + | <StructureSection load='4gmi' size='340' side='right'caption='[[4gmi]], [[Resolution|resolution]] 1.80Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4gmi]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[4gmi]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4GMI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4GMI FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=0XA:(4S,8E)-4-[(1R)-2-{[2-(5-TERT-BUTYL-1,3-OXAZOL-2-YL)PROPAN-2-YL]AMINO}-1-HYDROXYETHYL]-16-METHYL-6-OXA-3-AZABICYCLO[12.3.1]OCTADECA-1(18),8,14,16-TETRAENE-2,13-DIONE'>0XA</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=0XA:(4S,8E)-4-[(1R)-2-{[2-(5-TERT-BUTYL-1,3-OXAZOL-2-YL)PROPAN-2-YL]AMINO}-1-HYDROXYETHYL]-16-METHYL-6-OXA-3-AZABICYCLO[12.3.1]OCTADECA-1(18),8,14,16-TETRAENE-2,13-DIONE'>0XA</scene>, <scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene></td></tr> |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4gmi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4gmi OCA], [https://pdbe.org/4gmi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4gmi RCSB], [https://www.ebi.ac.uk/pdbsum/4gmi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4gmi ProSAT]</span></td></tr> | |
| - | + | ||
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/BACE1_HUMAN BACE1_HUMAN] Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves at the N-terminus of the A-beta peptide sequence, between residues 671 and 672 of APP, leads to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase.<ref>PMID:10677483</ref> <ref>PMID:20354142</ref> | ||
==See Also== | ==See Also== | ||
| - | *[[Beta secretase|Beta secretase]] | + | *[[Beta secretase 3D structures|Beta secretase 3D structures]] |
| + | == References == | ||
| + | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Derbyshire | + | [[Category: Derbyshire D]] |
| - | [[Category: Lindberg | + | [[Category: Lindberg JD]] |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571
| |||||||||||
